These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13338909)

  • 21. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of lysergic acid diethylamide upon performance of trained rats.
    WINTER CA; FLATAKER L
    Proc Soc Exp Biol Med; 1956 Jun; 92(2):285-9. PubMed ID: 13350323
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrophysiological analysis of psychotogenic drug action. I. Effect of LSD on specific afferent systems in the cat.
    PURPURA DP
    AMA Arch Neurol Psychiatry; 1956 Feb; 75(2):122-31. PubMed ID: 13282532
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain.
    SHORE PA; SILVER SL; BRODIE BB
    Science; 1955 Aug; 122(3163):284-5. PubMed ID: 13246633
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychophysiologic variables in the study of the effect of LSD-25 on cerebral blood flow and metabolism.
    PERLIN S
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Feb; (3):10-4. PubMed ID: 13310662
    [No Abstract]   [Full Text] [Related]  

  • 26. The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel.
    RINALDI F; HIMWICH HE
    J Nerv Ment Dis; 1955 Nov; 122(5):424-32. PubMed ID: 13320138
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of lysergic acid diethylamide on Betta splendens. II. Frenquel.
    TURNER WJ
    Dis Nerv Syst; 1956 Jun; 17(6):198. PubMed ID: 13330612
    [No Abstract]   [Full Text] [Related]  

  • 28. Some effects of bufotenine and lysergic acid diethylamide on the monkey.
    EVARTS EV
    AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):49-53. PubMed ID: 13275159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds].
    CERLETTI A; KONZETT H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146-8. PubMed ID: 13334586
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysergic acid diethylamide in patients with excess serotonin.
    SJOERDSMA A; KORNETSKY C; EVARTS EV
    AMA Arch Neurol Psychiatry; 1956 May; 75(5):488-92. PubMed ID: 13312730
    [No Abstract]   [Full Text] [Related]  

  • 31. Further observations on the effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    J Ment Sci; 1953 Oct; 99(417):804-8. PubMed ID: 13109462
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of the d-lysergic acid diethylamide on the psychic functions and on electroencephalogram.
    GASTAUT H; FERRER S; CASTELLS C; LESEVRE N; LUSCHNAT K
    Confin Neurol; 1953; 13(2):102-20. PubMed ID: 13060015
    [No Abstract]   [Full Text] [Related]  

  • 33. Lowered capillary resistance after iontophoresis of lysergic acid diethylamide.
    BLAIR EL; WAKEFIELD M; INGRAM GI; ARMITAGE P
    Nature; 1955 Sep; 176(4481):563. PubMed ID: 13265778
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychophysiological investigations in experimental psychoses; results of the exhibition of d-lysergic acid diethylamide to psychiatric patients.
    SLOANE B; DOUST JW
    J Ment Sci; 1954 Jan; 100(418):129-44. PubMed ID: 13152528
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on guppy Poecilia reticulatus chromatophores].
    CERLETTI A; BERDE B
    Experientia; 1955 Aug; 11(8):312-3. PubMed ID: 13262009
    [No Abstract]   [Full Text] [Related]  

  • 36. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.
    SALMOIRAGHI GC; SOLLERO L; PAGE IH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558
    [No Abstract]   [Full Text] [Related]  

  • 37. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].
    GIBERTI F; GREGORETTI L
    Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891
    [No Abstract]   [Full Text] [Related]  

  • 38. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD 25) in the animal body.
    STOLL A; ROTHLIN E; RUTSCHMANN J; SCHALCH WR
    Experientia; 1955 Oct; 11(10):396-7. PubMed ID: 13277462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.